Teva Pharmaceutical reported 3.33B in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Aspen Pharmacare APN:SJ 15.11B 92M
Cipla CIPLA:IN 45.44B 4.49B
Dr.Reddys Laboratories DRRD:IN 44.94B 4.71B
Guangzhou Baiy 600332:CH 14.87B 3.13B
Jiangsu Hengrui Me. 600276:CH 5.06B 113.59M
Kalbe Farma Tbk Pt KLBF:IJ 5379.4B 245.78B
Richter Gedeon RICHT:HB 119.49B 2.98B
Sh Fosun Pharma 600196:CH 6.73B 168.65M
Sun Pharmaceuticals SUNP:IN IR 81118.3M 4217.7M
Teva Pharmaceutical TEVA:IT 3.33B 220M